Advertisement
ENOV vs SNN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Buy and SNN is a Buy.
ENOV in upward trend: 10-day moving average crossed above 50-day moving average on October 27, 2026
The 10-day moving average for ENOV crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on ENOV as a result. In 54 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
ENOV moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +37.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in 154 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 100 of 182 cases where ENOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
ENOV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.060) is normal, around the industry mean (4.142). P/E Ratio (-1.407) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (3.441) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.466) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SNN in downward trend: price may drop because broke its higher Bollinger Band on November 04, 2026
SNN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In 23 of the 39 cases the stock fell afterwards. This puts the odds of success at 59%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for SNN moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 19 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on SNN as a result. In 43 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
The Moving Average Convergence Divergence (MACD) for SNN just turned positive on October 05, 2026. Looking at past instances where SNN's MACD turned positive, the stock continued to rise in 23 of 49 cases over the following month. The odds of a continued upward trend are 47%.
SNN moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SNN crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNN advanced for three days, in 191 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 111 of 202 cases where SNN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.517) is normal, around the industry mean (4.142). P/E Ratio (20.991) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.035) is also within normal values, averaging (11.253). Dividend Yield (0.039) settles around the average of (0.011) among similar stocks. P/S Ratio (1.905) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ENOV | SNN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 94 | |
SMR RATING 1..100 | 98 | 92 | |
PRICE GROWTH RATING 1..100 | 37 | 43 | |
P/E GROWTH RATING 1..100 | 48 | 80 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SNN's Valuation (54) in the Medical Specialties industry is in the same range as ENOV (72) in the Industrial Machinery industry. This means that SNN’s stock grew similarly to ENOV’s over the last 12 months.
SNN's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that SNN’s stock grew similarly to ENOV’s over the last 12 months.
SNN's SMR Rating (92) in the Medical Specialties industry is in the same range as ENOV (98) in the Industrial Machinery industry. This means that SNN’s stock grew similarly to ENOV’s over the last 12 months.
ENOV's Price Growth Rating (37) in the Industrial Machinery industry is in the same range as SNN (43) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to SNN’s over the last 12 months.
ENOV's P/E Growth Rating (48) in the Industrial Machinery industry is in the same range as SNN (80) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to SNN’s over the last 12 months.
| ENOV | SNN | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 58% | 3 days ago 56% |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 55% |
| Momentum ODDS (%) | 3 days ago 68% | 3 days ago 52% |
| MACD ODDS (%) | N/A | 5 days ago 47% |
| TrendWeek ODDS (%) | 3 days ago 66% | 3 days ago 56% |
| TrendMonth ODDS (%) | 3 days ago 63% | 3 days ago 58% |
| Advances ODDS (%) | 4 days ago 61% | 11 days ago 58% |
| Declines ODDS (%) | N/A | 3 days ago 57% |
| BollingerBands ODDS (%) | 3 days ago 66% | 3 days ago 59% |
| Aroon ODDS (%) | 3 days ago 55% | 3 days ago 55% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green while SNN’s FA Score has 0 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- SNN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 5 TA indicator(s) are bullish while SNN’s TA Score has 6 bullish TA indicator(s).
- ENOV’s TA Score: 5 bullish, 3 bearish.
- SNN’s TA Score: 6 bullish, 4 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а +36.41% price change this week, while SNN (@Medical/Nursing Services) price change was +4.88% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.27%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was -7.48%.
Reported Earning Dates
ENOV is expected to report earnings on Feb 25, 2027.
SNN is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Medical/Nursing Services (-3.27% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -5.10% | ||
| FELE - ENOV | 56% Loosely correlated | -1.81% | ||
| DOV - ENOV | 55% Loosely correlated | +0.64% | ||
| PH - ENOV | 53% Loosely correlated | +2.86% | ||
| ITT - ENOV | 52% Loosely correlated | +4.92% | ||
| KMT - ENOV | 51% Loosely correlated | -0.95% | ||
More | ||||
SNN and
Correlation & Price change
A.I.dvisor indicates that over the last year, SNN has been loosely correlated with MDT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then MDT could also see price increases.
| Ticker / NAME | Correlation To SNN | 1D Price Change % | ||
|---|---|---|---|---|
| SNN | 100% | -2.69% | ||
| MDT - SNN | 56% Loosely correlated | -2.90% | ||
| SYK - SNN | 56% Loosely correlated | -2.75% | ||
| ZBH - SNN | 52% Loosely correlated | -1.18% | ||
| OFIX - SNN | 47% Loosely correlated | -11.77% | ||
| ENOV - SNN | 46% Loosely correlated | -5.10% | ||
More | ||||